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Abstract 
Objectives: There has been considerable change in the practice of deceased kidney 
transplantation in the past 15 years with more extreme phenotypes implanted. The impact of 
this change in clinical outcomes is unclear. The primary aim of this study was to determine 
whether the increased use of expanded criteria donors – note this is not ECD my be worth 
shortening this to eCD as opposed to ECD (extended criteria donors –ECD and donors after 
circulatory death - DCD) affected clinical outcomes, including the incidence and pattern of 
delayed graft function (DGF). 
Methods and Materials: A retrospective analysis of 1359 renal transplants was performed in a 
single unit over the course of 15 years. The first 10 years of data (group 1) were compared 
with the subsequent 5 years (group 2). Patient and donor characteristics were recorded. 
Patient and graft outcomes were analysed at 6 months and 12 months post-transplant, in 
addition to serum creatinine and patterns of DGF (post-transplant times: on haemodialysis, to 
peak creatinine, for creatinine to half, for creatinine to fall within 10% of baseline). 
Results: There was a significant increase in the percentage of eCD allografts used in group 2, 
with a significant increase in the incidence of DGF. Despite this, the clinical outcomes were 
better - serum creatinine measured at 1 year and the incidence of biopsy proven acute 
rejection was less than half group 1. Graft and patient survival at 1 year were the same in 
both groups. Cold ischaemic time (CIT) was significantly reduced in group 2. Regarding the 
pattern of DGF, group 2 eCD kidneys had a significantly lower incidence of Type 1 DGF and 
a significantly higher incidence of Types 3 & 4 DGF. Time for creatinine to half in both 
groups was the best predictor of a serum creatinine <180 at 1 year, confirming previous 
reports. 
Conclusion: The increased use of eCD kidneys (DCD and ECD) has led to a higher incidence 
of DGF, however the pattern has shown that, in this group of patients, the requirement for 
haemodialysis has significantly reduced. Long-term outcomes have not been affected. The 
key marker of future allograft function remained the time for creatinine to half in both the 
older and more recent more extreme cohort. 
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Introduction 
 
Delayed graft function (DGF) following renal transplantation is a common phenomenon and 
may be an important prognostic indicator of future graft functioni. Higher incidences have 
been attributed to the increasing use of donors from more expanded criteria (eCD), such as 
extended criteria donors (ECD)ii and donation after cardiac death (DCD) donors. Various 
definitions of DGF have been describediii with the most cited describing it as “the need for 
dialysis in the first week after transplant”iv. Aitken et al. have described four patterns of 
DGF, namely (1) a prolonged haemodialysis (HD): a prolonged period of haemodialysis 
followed by a fall in creatinine; (2) a single haemodialysis (HD1): a one-off session of 
haemodialysis prior to fall in creatinine; (3) a slow decline (SD): an immediate reduction in 
creatinine followed by a slow decline with more than 7 days required for the creatinine to 
half; and (4) slow rise then a gradual decline (SR): initial rise in creatinine followed by a 
slow decline with more than 7 days for creatinine to half with no requirement for dialysisv. It 
seems likely that these clearly defined patterns reflect a complex interaction between the 
susceptibility of the organ from pre-donation morbidity, and donation processes themselves 
(e.g. cold ischaemic time). Over the past 10 years there has been considerable change in 
deceased renal transplantation with a trend towards more extreme phenotypes being 
implantedvi and in improving the processes of transplantation e.g. reducing cold ischaemic 
times. The aim of this study was to determine whether the increased use of eCD (DCD and 
extended criteria donors (ECD)) affected clinical outcomes, particularly the incidence, 
outcomes and patterns of delayed graft function (DGF). 
 
Methodology 
 
A retrospective analysis of 1359 renal transplants was performed in a single unit over the 
course of 15 years. The first 10 years of data (group 1) were compared with the subsequent 5 
years (group 2). Data from group 1 had been previously analysed and published by Aitken et 
alv. 
 
Prior to relocation in 2015 to the Queen Elizabeth University Hospital, Glasgow, the renal 
transplant unit was based in the Western Infirmary, Glasgow. The unit itself, its catchment 
area and processes remain unchanged as a tertiary referral centre for the West of Scotland and 
serves an approximate 2.6 million people. Transplants performed in patients under the age of 
18 years were excluded. 
 
Donor and recipient demographic data were collated. The primary outcome measure was the 
pattern of DGF. Secondary outcome measures included cold ischaemic time (CIT), creatinine 
at 12 months post transplant and biopsy proven acute rejection (BPAR).  
 
Extended Criteria Donor (ECD) kidneys were defined as those from donors aged 60 years or 
above or those aged between 50 - 59 years with at least 2 of the following co-morbidities: 
high blood pressure, serum creatinine >1.5 mg/dl, or death arising from a cerebrovascular 
accident (CVA). 
 
Our definition of DGF was the requirement for haemodialysis or the serum creatinine failing 
to halve during the initial 7 days post- transplant. 
 
Protocols were in keeping with guidelines as per 1975 Helsinki Declaration. 
 
Results 
 
762 patients underwent renal transplantation between 2001 and 2010. 597 patients were 
transplanted between 2010 and 2015 which represents a 56.7% increase in transplantation 
rate in group 2 – the more recent time group. This was largely due to the increase in the 
number of DCD kidneys transplanted. ECD kidneys represented 21.3% of allografts in group 
1 compared with 30.2% in group 2. The CIT was significantly reduced in the more recent 
time group 2 (Group 1. 13.47hr vs. 9.75hr in Group 2). BPAR was also significantly reduced 
in group 2 (22.4% vs. 11.1%).  Further demographic data has been summarised in Table 1. 
 
 
Table 1 
 
 
Overall, 24.9% of group 1 vs. 32.7% of group 2 patients had DGF (p=0.0015). With regard 
the pattern of DGF in DCD kidneys, there was no significant difference in the incidence of 
Type 1, 2 or 4 DGF between the groups. There was, however a significant decrease in Type 3 
DGF in group 2 (Table 2). With respect to ECD kidneys, there was a significant decreased 
incidence of Type 1 DGF in group 2 and a corresponding increase in Type 2 and 4 DGF in 
group 2. There was no significant difference in Type 3. 
 
 
Table 2 
 
 
Table 3 outlines the effect of pattern of DGF on 1-year graft and patient survival. In addition  
mean serum creatinine at 1 year is shown for each pattern and also for time on haemodialysis 
(tHD), time for creatinine to half (t½), time for creatinine to fall within 10% of baseline (t10%) 
and gradient of creatinine decline (Crgrad). There was no association between the patterns of 
DGF with regard to graft or patient survival. The serum creatinine at 1 year was lower in all 
patterns of DGF in the more recent time period - group 2, but significance was only achieved 
in Type 1. In group 2, t½ 10-15 days was associated with the highest serum creatinine at 1 
year which differed from group 1 data for which the highest serum creatinine was found to be 
in t½  > 15 days. 
 
Table 3 
 
 
As was the case with group 1, patients with serum creatinine >180µmol/L at 1 year had 
longer tHD and t½ compared with those with serum creatinine levels <180µmol/L (Table 4). 
The same applied to Crmin (best creatinine in the first 30 days after transplant) with higher 
levels being found in those with serum creatinine levels >180µmol/L. Significance was also 
found for t10% and also Crmax (maximum creatinine) with serum creatinine >180µmol/L at 1 
year associated with higher levels respectively. 
 
Table 4 
 
 
In group 1, tHD t½ and Crgrad were found to be the best predictors of a serum creatinine 
≤180µmol/L at 1 yearv. In group 2, tpeak (time to peak creatinine) of 2.5days (sensitivity 
58.5%, specificity 55.7%, area under the curve 0.60), t½ 6.5 days (sensitivity 70.6%, 
specificity 70.8%, area under the curve 0.73) and t10% 13.5 days (sensitivity 58.8%, specificity 
64.9%, area under the curve 0.66) were the best predictors of a serum creatinine ≤180µmol/L 
at 1 year (Table 5).  
 
 
  
 
Table 5 
 
 
 
In order to further delineate the influence of DGF on long-term outcomes we compared group 
2 SCD and ECD grafts which were either DCD or DBD. Of the 195 DGF patients in group 2 
there were 41 SCD DBD (21%), 42 SCD DCD (21.5%), 35 ECD DBD (17.9%) and 31 ECD 
SCD kidneys (15.9%). The results are summarised in Table 6. 
 
Table 6 
 
 
Discussion 
 
Given the rapid changes to the quality of organs offered for transplantation, the differing 
recipient profile, and the improvements in the transplantation processes, a surrogate marker 
of patient and graft outcome is desirable. DGF may be such a marker and thus we report the 
impact of practice changes on the patterns of DGF and their relationship to ultimate long-
term outcomes. 
  
This study has found that the pattern of DGF was different between the two earlier and later 
groups, however long-term outcomes have not been affected and indeed with respect to 
serum creatinine levels, at 1 year these have improved considerably. Interestingly, this study 
confirms that the key marker of future allograft function remained the time for creatinine to 
half in both the older and more recent more extreme cohort, reflecting the physiological 
capacity of the respective organs. 
 
The relationship between ECD kidneys, DGF and long-term outcomes thereof has multi-
factorial influences and it is difficult to determine with certainty the influence each factor 
plays. It has been well established the effect of CIT on DGFvii and it was encouraging to 
show that our CIT have significantly reduced. Despite this, the incidence of DGF has 
increased and it would be logical to conclude that the donor characteristics and type of 
donation (DCD/ DBD) contribute  more significantly to the development of DGF than CIT. 
Conversely, the increased use of ECD kidneys has not affected one year outcomes and we 
hypothesise that the significantly reduced CIT may be the main reason for improving clinical 
outcomes, as this would be predicted to reduce physiological stress on the allograft. 
 
The difference seen in the pattern of DGF is interesting. The overall trend is that in those 
patients who develop DGF, there is a reduced requirement of multiple haemodialysis 
sessions. This would appear to be the significant change in the pattern of DGF in ECD 
kidneys, the consequence of which has led to a proportionate change in the other types. With 
respect to DCD kidneys, the changes between groups 1 and 2 are less pronounced with no 
significant differences found for those requiring haemodialysis post-transplantation. This 
perhaps is less surprising as the major shift in the latter 5 years of the study has not been with 
regard to the quality of DCD kidneys, but rather toward the use of older kidneys hence the 
major changes seen are those in the ECD group.  
 
The reduced incidence of BPAR in more recent times (group 2) is also encouraging but this is 
hard to explain with merely better matching of donor to recipient. Other factors seem unlikely 
to be sufficient to be the cause of this such as a slightly older age group, or no observable 
change in immunosuppression practice. It may be that a longer time on haemodialysis before 
transplantation may lead to a reduced immune-vigilance, but we do not have data on this 
currently.  
 
We would conclude that the increased use of ECD kidneys has not negatively affected the 
short-term outcomes in these patients. It will be interesting to compare the longer-term 
outcomes of the ECD kidneys.  
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